Results: 11
Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 105, doi. 10.15252/emmm.201505456
- By:
- Publication type:
- Article
Targeting netrin-1/ DCC interaction in diffuse large B-cell and mantle cell lymphomas.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 96, doi. 10.15252/emmm.201505480
- By:
- Publication type:
- Article
IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 155, doi. 10.15252/emmm.201505395
- By:
- Publication type:
- Article
Concise gene signature for point-of-care classification of tuberculosis.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 86, doi. 10.15252/emmm.201505790
- By:
- Publication type:
- Article
Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 139, doi. 10.15252/emmm.201505644
- By:
- Publication type:
- Article
CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer: a personalized molecular surgical therapy.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 83, doi. 10.15252/emmm.201506006
- By:
- Publication type:
- Article
Pancreatic cancer microenvironment, to target or not to target?
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 80, doi. 10.15252/emmm.201505948
- By:
- Publication type:
- Article
Sequential treatment with 5-aza-2′-deoxycytidine and deacetylase inhibitors reactivates HIV-1.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 117, doi. 10.15252/emmm.201505557
- By:
- Publication type:
- Article
On the road to replication.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 77, doi. 10.15252/emmm.201505965
- By:
- Publication type:
- Article
The awesome lysosome.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 73, doi. 10.15252/emmm.201505966
- By:
- Publication type:
- Article
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 2, p. 171, doi. 10.15252/emmm.201506162
- By:
- Publication type:
- Article